検索結果

e pathophysiology of geographic atrophy secondary to age-related macular degeneration and the complement pathway as a therapeutic target. Retina. 2017;37(5):819-835. 2 Cheung, C.M.G., Chen, Y., Holz, ...

ブロナック点眼液0.1%に関するよくあるご質問

（0.24） － 1（0.03） 臨床検査 － 1（0.03） 1（0.03） 　眼圧上昇 － 1（0.03） 1（0.03） （再審査終了時集計） ※1 重複を除く施設数。 ※2 「副作用の種類」はMedDRA（Ver.8.1）LLTで示した。 ※3 MedDRA（Ver.8.1）LLTに、報告名である「角膜上皮剝離」がないため、「角膜上皮欠損」としている。 ※4 器官別大分類は発現症例数（率）...

General Announcement: July 8, 2024 Senju Pharmaceutical Co., Ltd. Notice of Orphan Drug Designation for SJP-0008 as a Treatment of Central Retinal Artery Occlusion Senju Pharmaceutical Co., Ltd. (Head...

Ethical Products for Medical Professionals | Business Activities | About Senju | SENJU Pharmaceutical

of our premier line of ophthalmological drugs has launched our entry into other promising fields of medicine Senju Pharmaceutical greatly values the clinical experience of medical professionals active...

Over-The-Counter Medicines | Business Activities | About Senju | SENJU Pharmaceutical

t and one of the most respected brands in the OTC field. We have also devoted our energies to the timely development of contact lens products to meet the rising demand in this area. These as well as t...